V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 210035052 | 210038143 | 1.73 | 63 | Palliative (P) | 2015-10-09 | 2015-10-12 | Dasatinib | N | N | 210037781 | DASATINIB |
| 210035053 | 210012880 | 1.68 | 65.5 | Palliative (P) | null | 2017-06-01 | CNS LGG 2004 03 vinc weekly+ carbo | N | N | 210037785 | CARBOPLATIN + VINCRISTINE |
| 210035054 | 210012889 | 0 | null | Palliative (P) | 2016-08-05 | 2016-12-14 | RIALTO TRIAL | N | N | 210037803 | BENDAMUSTINE |
| 210035055 | 210027895 | 0 | 14.8 | Palliative (P) | 2018-06-23 | 2018-07-11 | LOMUSTINE + PROCARBAZINE | N | N | 210037983 | LOMUSTINE + PROCARBAZINE |
| 210035056 | 210012918 | null | 79.3 | Adjuvant (A) | 2018-01-11 | 2018-05-15 | CARBOPLATIN + ETOPOSIDE | N | N | 210038029 | CHOP |
| 210035057 | 210012926 | null | 65.2 | Curative (C) | 2018-05-30 | 2018-05-30 | RIALTO TRIAL | N | N | 210038057 | CARBOPLATIN + ETOPOSIDE |
| 210035058 | 210012940 | 1.71 | 100 | Curative (C) | 2014-11-24 | 2016-05-01 | Erwinase (Erwinia Asparaginase) | 02 | N | 210038126 | BENDAMUSTINE |
| 210035059 | 210012944 | 1.71 | 14 | Curative (C) | 2017-09-25 | 2018-05-14 | Cyclophosphamide TBI Allograft | Y | N | 210038157 | CYCLOPHOSPHAMIDE |
| 210035060 | 210022154 | 1.73 | 90 | Curative (C) | 2012-05-29 | 2015-05-23 | Erwinase (Erwinia Asparaginase) | N | null | 210038174 | ERWINIA ASPARAGINASE |
| 210035061 | 210027907 | null | 13.3 | Curative (C) | 2020-03-16 | 2020-04-25 | Erwinase (Erwinia Asparaginase) | 01 | null | 210038187 | ERWINIA ASPARAGINASE |
| 210035062 | 210012960 | 1.56 | 54.8 | Disease modification (D) | 2015-11-06 | 2016-02-01 | Bendamustine + prednisolone | N | N | 210038211 | METHOTREXATE HIGH DOSE |
| 210035063 | 210012963 | null | 0 | Curative (C) | 2014-03-30 | 2014-06-29 | CNS LGG 2004 03 vinc weekly+ carbo | N | null | 210038222 | CARBOPLATIN + VINCRISTINE |
| 210035064 | 210031415 | 0 | 66 | Palliative (P) | null | 2014-07-29 | CHLORAMBUCIL + OFATUMUMAB | null | Y | 210038235 | CHLORAMBUCIL + OFATUMUMAB |
| 210035065 | 210012982 | 1.63 | 70.8 | Curative (C) | 2017-08-17 | 2017-08-17 | LOMUSTINE + PROCARBAZINE | N | N | 210038298 | LOMUSTINE + PROCARBAZINE |
| 210035066 | 210012984 | 1.8 | 77 | Not known (9) | 2016-11-14 | 2016-11-14 | LOMUSTINE + PROCARBAZINE | 02 | null | 210038312 | LOMUSTINE + PROCARBAZINE |
| 210035067 | 210012991 | null | 88.4 | Curative (C) | 2018-07-25 | 2018-09-20 | Cladribine IV weekly | N | N | 210038321 | CLADRIBINE |
| 210035068 | 210013003 | 1.8 | null | Curative (C) | 2013-11-22 | 2014-01-03 | CARBOPLATIN + ETOPOSIDE | N | N | 210038363 | CYCLOPHOSPHAMIDE + VINCRISTINE |
| 210035069 | 210013005 | 0 | 81 | Curative (C) | 2013-06-28 | 2013-09-20 | CYCLOPHOSPHAMIDE | N | null | 210038377 | CYCLOPHOSPHAMIDE |
| 210035070 | 210022183 | 1.85 | 119 | Curative (C) | 2018-05-05 | 2018-05-15 | PONATINIB | N | N | 210038442 | IDELALISIB |
| 210035071 | 210022189 | 1.8 | 25.5 | Curative (C) | 2018-02-26 | 2018-04-19 | Nelarabine | N | N | 210038500 | BEVACIZUMAB |
| 210035072 | 210013037 | 1.88 | 71.7 | Disease modification (D) | 2018-03-26 | 2019-01-02 | Pentostatin | 02 | N | 210038553 | CARBOPLATIN + ETOPOSIDE |
| 210035073 | 210031426 | null | null | Disease modification (D) | 2014-01-19 | 2014-06-20 | Erwinase (Erwinia Asparaginase) | N | N | 210038557 | UKALL XII |
| 210035074 | 210013042 | 0 | 79 | Palliative (P) | 2013-12-27 | 2014-02-04 | Procarbazine | 2 | N | 210038560 | PROCARBAZINE |
| 210035075 | 210013063 | 1.82 | null | null | 2017-10-11 | 2017-10-12 | CHOP - 21 days | N | N | 210038656 | IDELALISIB |
| 210035076 | 210013068 | 1.82 | 83.55 | null | 2018-03-16 | 2018-05-07 | Methotrexate High Dose (3g/m2) | N | N | 210038669 | PENTOSTATIN |
| 210035077 | 210022224 | null | 15.8 | Curative (C) | 2015-03-29 | 2015-11-30 | Dasatinib | N | N | 210038791 | DASATINIB |
| 210035078 | 210013107 | 1.58 | 52.6 | Curative (C) | 2017-11-22 | 2018-04-20 | BENDAMUSTINE | null | null | 210038851 | METHOTREXATE HIGH DOSE |
| 210035079 | 210022229 | 1.72 | 101 | Curative (C) | 2017-01-30 | 2017-01-30 | CYCLOPHOSPHAMIDE + FLUDARABINE | N | N | 210038868 | CYCLOPHOSPHAMIDE + FLUDARABINE |
| 210035080 | 210013113 | 1.74 | null | null | 2016-07-21 | 2016-07-27 | LOMUSTINE + PROCARBAZINE | N | N | 210038885 | LOMUSTINE + PROCARBAZINE |
| 210035081 | 210013126 | 1.59 | 66 | Curative (C) | null | 2019-01-27 | Cladribine (subcut) 5 days | N | N | 210038930 | CLADRIBINE |
| 210035082 | 210013132 | 1.7 | 29.9 | Palliative (P) | null | 2016-12-06 | Inotuzumab Ozogamicin | N | N | 210038940 | INOTUZUMAB OZOGAMICIN |
| 210035083 | 210022249 | 0 | 56 | Palliative (P) | 2019-10-29 | 2019-12-25 | CARBOPLATIN + VINCRISTINE | N | N | 210039036 | CARBOPLATIN + VINCRISTINE |
| 210035084 | 210013152 | null | 75.1 | Palliative (P) | 2016-05-15 | 2016-07-18 | CHLORAMBUCIL + OFATUMUMAB | 2 | N | 210039055 | UKALL XII |
| 210035085 | 210013155 | 1.68 | 65.8 | Palliative (P) | 2012-02-25 | 2013-11-18 | RIALTO TRIAL | Y | N | 210039065 | BENDAMUSTINE |
| 210035086 | 210013167 | null | 65.15 | null | 2014-01-08 | 2014-01-19 | CLADRIBINE | N | null | 210039110 | CLADRIBINE |
| 210035087 | 210013173 | 1.56 | 41.2 | Palliative (P) | null | 2018-07-29 | IDELALISIB | N | N | 210039146 | CHLORAMBUCIL + OFATUMUMAB |
| 210035088 | 210013176 | null | 65.4 | Palliative (P) | 2017-08-05 | 2017-08-05 | CYCLOPHOSPHAMIDE + FLUDARABINE | N | null | 210039158 | CYCLOPHOSPHAMIDE + FLUDARABINE |
| 210035089 | 210022270 | 1.67 | null | Disease modification (D) | 2019-06-27 | 2019-06-30 | Vinblastine weekly | 02 | N | 210039177 | VINBLASTINE |
| 210035090 | 210013182 | 1.35 | 59 | null | 2017-01-20 | 2017-07-21 | Bevacizumab 7.5mg/kg | null | N | 210039186 | CHLORAMBUCIL + OFATUMUMAB |
| 210035091 | 210013188 | 1.76 | null | Curative (C) | null | 2015-01-01 | CARBOPLATIN + VINCRISTINE | 02 | N | 210039212 | CARBOPLATIN + VINCRISTINE |
| 210035092 | 210013190 | 1.6 | null | Palliative (P) | 2017-08-15 | 2017-08-16 | CYCLOPHOSPHAMIDE | 02 | N | 210039213 | CYCLOPHOSPHAMIDE |
| 210035093 | 210013193 | 1.87 | 0 | Curative (C) | 2015-09-30 | 2015-11-11 | Erwinase (Erwinia Asparaginase) | N | N | 210039241 | CVP R |
| 210035094 | 210013197 | 1.56 | 65.5 | Curative (C) | 2015-02-19 | 2015-05-02 | Bevacizumab 7.5mg/kg | N | N | 210039270 | BENDAMUSTINE |
| 210035095 | 210013211 | 1.72 | null | null | null | 2016-01-15 | Bendamustine +/- Prednisolone | N | N | 210039328 | PONATINIB |
| 210035096 | 210013232 | 1.64 | 88.1 | Palliative (P) | 2019-02-26 | 2019-02-26 | Procarbazine | N | N | 210039421 | PROCARBAZINE |
| 210035097 | 210013238 | 1.77 | null | Palliative (P) | 2016-02-08 | 2016-04-30 | UKALL XII Consolidation 2 & 4 | null | N | 210039434 | CYCLOPHOSPHAMIDE + VINCRISTINE |
| 210035098 | 210013248 | 1.62 | 26.45 | null | 2016-03-09 | 2016-03-09 | RIALTO TRIAL | N | null | 210039493 | METHOTREXATE HIGH DOSE |
| 210035099 | 210013257 | null | null | null | 2019-02-02 | 2019-02-10 | Methotrexate High Dose (3g/m2) | 2 | N | 210039592 | IDELALISIB |
| 210035100 | 210013259 | 1.73 | 79.2 | Palliative (P) | 2015-10-31 | 2015-11-05 | CNS LGG 2004 03 vinc weekly+ carbo | N | N | 210039601 | CARBOPLATIN + VINCRISTINE |
| 210035101 | 210013270 | 1.83 | 74.2 | Curative (C) | 2018-07-13 | 2018-07-27 | Dasatinib | N | N | 210039685 | DASATINIB |